News About: Med. Insurance
High-priced 693 items to be re-evaluated in 2009
The Korea Insurance Review and Assessment Service announced on December 23 that it will re-evaluate the economic effectiveness of expensive 693 drugs (583 ingredients) in the first quarter of next year, down 77 items ...
Januvia get listed in health insurance
The national health insurance has covered Merck’s Januvia, a new treatment option for type 2 diabetes, from this month, according to the National Health Insurance Corporation. The insurance price of Januvia tablet is ...
Government to freeze health insurance premium
The Ministry for Health, Welfare and Family Affairs announced on November 27 that it decided to freeze the National Health Insurance premium for 2009 for the first time ever, despite expanded coverage as economic diff...
35 new drugs get listed for this year’s insurance coverage
The National Health Insurance Corporation (NHIC) announced on November 24 that of 59 new medicines being applied for an insurance-eligible list, 34 new medicines were successfully put on the positive list as of Octobe...
226 items to benefit from health insurance
The Ministry of Health, Welfare and Family Affairs announced on November 21 that 226 medicines including MSD’s Januvia will be eligible for health insurance from next month.
The ministry also said that 26 items inc...
Benefits over ban of duplicate prescriptions of same ingredient are minimal
The government plans to discourage the reissued prescriptions of same ingredient in fear that it will not be help to helpful to the budget for national health insurance, but such measure is not deemed economical, acco...
HIRA clarifies screening results of cholesterol-lowering agents
The Health Insurance Review and Assessment Service (HIRA) reaffirmed its position over the results of lipid-lowering medicines, saying its assessment was made based on their clinical and cost effectiveness profiles.
...
Use of generic drugs in hospital
The overall use of generic products in the hospital dispensing has been moderately increased, according to a local survey.
In the survey of prescriptions issued between May 10, 2003 and October 13, 2008, Bundang Se...
Evaluation method of cholesterol-lowering agents lack rationale, civic groups say
Civic groups advocating consumer rights, including the Korean Pharmacists for Democratic Society (KPRS), said in a recent statement that Pfizer and AstraZeneca profiteered 30.7 billion won due to the Health Insurance ...
WHO suggests use of domestically-made generic drugsKorea should introduce a new prescription plan, under which doctors will have to make prescriptions listing only chemical ingredients instead of the names of specific products, ...
|
